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Background: Anxiety and depression are prevalent in patients with chronic illness,
but there are limited data in adults with CF. This study draws on a sub-set
of data collected for the UK arm of the International Depression & Anxiety
Epidemiological Study (TIDES) together with additional clinical data. Our aim
was to explore the relationship between clinical variables and anxiety in order to
identify signiﬁcant correlates with anxiety in adult CF patients.
Methods: Data were collected from CF patients at the West Midlands Adult
CF Centre using the Hospital Anxiety and Depression Scale (HADS) plus clinical
data including age, sex, BMI, spirometry, history of haemoptysis. These variables
were entered into the regression model. We intended to include use of IV antibiotics
and recent diagnosis of diabetes as additional variables however, there was insuf-
ﬁcient variability within our sample to conform to the requirements for regression
analysis.
Results: 139 patients took part (78 male), mean age 28 yrs, mean FEV1 64 pre-
dicted, mean BMI 22.7 kg/m2. 38.9% of participants had clinically signiﬁcant
anxiety scores. The distribution of variables was checked for assumptions for
regression analysis. The signiﬁcant variables were FEV1% predicted (poorer lung
function associated with higher anxiety), BMI (higher BMI associated with higher
anxiety) and haemoptysis (higher anxiety scores for those with recent haemoptysis).
This regression model only accounted for 16.8% of variance in anxiety.
Discussion: The association of poor lung function and recent haemoptysis with high
anxiety is not surprising, however the relationship with higher BMI and anxiety is
unexpected.
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Introduction: Patients with CF may have a high prevalence of depression and
anxiety, which can affect their quality of life (QoL).
Objective: To assess QoL in a group of adult CF patients and its relation with
symptoms of depression and anxiety.
Methods: The St George’s respiratory questionnaire (SGRQ), the CF Questionnaire
Revised for adolescent and adults (CFQR-14+), the Hospital Anxiety and Depres-
sion Scale (HADS) and the Center for Epidemiological Studies-Depression Scale
(CES-D) were administered. Data were collected on clinical, nutritional, respiratory
function, HRCT and laboratory parameters.
Results: The questionnaires were completed by 43 patients; 33.3% were classiﬁed
as depressive (CES-D), 21.7% had depression symptoms (HADS-D) and 31.5% had
anxiety symptoms (HADS-A). Signiﬁcant positive correlations were found between
depression and anxiety and all the CRSG scales; and negative correlations with all
the CFQR-14+ items. The patients with a positive screening for depression and/or
anxiety had signiﬁcantly higher scores than those patients without depression or
anxiety with all the CRSG scales and lower scores for almost all the CFQR-14+
items. Patients with depression and/or anxiety and FEV1(%) 50% had a signif-
icantly worse quality of life than those who had a negative screening but with
FEV1(%)< 50%, in almost all the items.
Conclusions:
1. Patients with CF from our sample had an increased prevalence of symptoms of
depression and anxiety, similar to other series.
2. Patients with CF and symptoms of depression and/or anxiety had a worse QoL, as
measured by CRSG and CFQR-14+, than CF patients without these symptoms,
regardless of their pulmonary function.
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Background: Research demonstrated that individuals with cystic ﬁbrosis are at
increased risk for psychological difﬁculties. As these psychological outcomes can
vary considerably across affected individuals, it is necessary to identify factors that
are associated with these differences in outcome.
Objectives: This study prospectively investigated the role of acceptance in relation
to self-reported anxiety and depression in adolescents with CF. It was hypothesized
that greater acceptance would be related to less anxiety and depression, whilst
controlling for illness severity (FEV1% predicted).
Methods: Forty adolescents with CF (23 boys, 17 girls; 14−22 years) participated.
Anxiety and depression were assessed using the Hospital Anxiety and Depression
Scale (HADS). Acceptance was assessed with the Illness Cognition Questionnaire
(Time 1). After 6 months the HADS was reassessed (Time 2).
Results: Hierarchical regression analyses were performed to examine the role of
acceptance in anxiety and depression. Whilst controlling for illness severity, greater
acceptance at Time 1 was related to lower anxiety and depression at Time 1, as
well as lower depression at Time 2.
Conclusions: Results suggest that acceptance
a. should be taken into account in the multidisciplinary treatment of those individ-
uals with cystic ﬁbrosis who exhibit psychological difﬁculties, and
b. can be important in the prevention of depression. Addressing depression might
also have indirect positive effects on health outcomes, as depression relates to
poorer disease management.
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Background: Advances in the management of cystic ﬁbrosis (CF) have led
to a signiﬁcant improvement in survival although marked differences between
individuals are still observed. It is unknown whether the ways in which adults
with CF cope predict survival.
Methods: Between June and September 1999 a consecutive series of 116 patients
were recruited to evaluate the Cystic Fibrosis Coping Questionnaire. Demographic
(age, gender), clinical (FEV1% predicted, BMI, diabetes, B. Cepacia complex, in-
travenous access device, nutritional and lung transplant status) and coping variables
(optimism, distraction) were recorded. Kaplan-Meier methods and Cox proportional
hazards models examined associations between coping and survival.
Results: At the census date (31st December 2009) 86 adults were alive, 28 had died
and two were lost to follow-up. Initial analyses suggested a statistically signiﬁcant
association between optimism and survival. However, it is known that several
variables, notably disease severity, predict survival and when these are suitably
modelled the apparent association between optimism and survival becomes doubtful.
Furthermore, any association in the initial analyses became unclear after the removal
of the seven patients with B. Cepacia complex.
Conclusions: This work illustrates the importance of careful modelling on suitable
data sets taking account of known prognostic variables. The fact that we did not ﬁnd
a statistically signiﬁcant association does not mean that there is no real association
between coping and survival. Appropriate testing would require a large sample with
a high number of deaths.
